Active Ingredient(s): Rituximab
FDA Approved: * November 26, 1997
Pharm Company: * GENENTECH
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Rituxan Overview

Rituximab, sold under the brand name Rituxan, is a medication used to treat certain autoimmune diseases and types of cancer.[8] It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia(in non-geriatric patients), rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura, pemphigus vulgaris, myasthenia gravis and Epstein–Barr virus-positive mucocutaneous ulcers.[8][9][10][11...

Read more Rituxan Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Rituximab

Recent Rituxan Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 100mg, 100mg/10ml(10mg/ml), 10mg/ml, 500mg, 500mg/50ml(10mg/ml)
  • Solution: 100mg/10ml (10mg/ml), 500mg/50ml (10mg/ml)
  • Vial: 10mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Rituxan: (2 results)

Sorted by National Drug Code
  • 50242-051 Rituxan 10 mg/ml Intravenous Injection, Solution by Genentech, Inc.
  • 50242-053 Rituxan 10 mg/ml Intravenous Injection, Solution by Genentech, Inc.

Other drugs which contain Rituximab or a similar ingredient: (9 results)